Zhejiang Hisun Pharmaceutical Co. Ltd.

Quick facts

Marketed products

• Ademethionine · Other
• Ademetionine 1 · Hepatology / Gastroenterology
  Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function.
• Ademetionine 2 · Hepatology / Gastroenterology
  Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function.
• Ademetionine 3 · Hepatology / Gastroenterology
  Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function.
• Polyene Phosphatidyl choline

Phase 3 pipeline

• Actemra +MTX · Immunology
  Actemra (tocilizumab) is an IL-6 receptor antagonist that blocks interleukin-6 signaling to reduce inflammatory responses, used in combination with methotrexate (MTX) for rheumatoid arthritis.
• HS-25 · Diabetes
  HS-25 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
• HS-25 and Atorvastatin · Cardiovascular
  HS-25 is a combination therapy where HS-25 (an investigational agent) is co-administered with atorvastatin, a statin that inhibits HMG-CoA reductase to lower cholesterol.
• HS022 · Oncology
  HS022 is a small molecule inhibitor targeting a specific kinase involved in cancer cell proliferation and survival.
• HS628+MTX · Immunology / Rheumatology
  HS628 is a small-molecule inhibitor combined with methotrexate (MTX) to target immune-mediated inflammatory conditions through dual pathway suppression.
• Placebe of HS-25 and Atorvastatin · Cardiovascular
  Atorvastatin is a statin that inhibits HMG-CoA reductase to lower cholesterol levels.
• Placebo of HS-25
  This is a placebo control arm and contains no active pharmaceutical ingredient.
• Vinorelbine Bitartrate · Oncology
  Vinorelbine bitartrate is a semi-synthetic vinca alkaloid that inhibits microtubule assembly by binding to tubulin, thereby disrupting cell division and inducing apoptosis in cancer cells.

Phase 2 pipeline

• AST-3424
• Regorafenib Tablets

Phase 1 pipeline

• HS269
• HS387

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Zhejiang Hisun Pharmaceutical Co. Ltd. portfolio CI brief
• Zhejiang Hisun Pharmaceutical Co. Ltd. pipeline updates RSS

Frequently asked questions about Zhejiang Hisun Pharmaceutical Co. Ltd.

Related

• Ademethionine · Other
• Ademetionine 1 · Hepatology / Gastroenterology
• Ademetionine 2 · Hepatology / Gastroenterology
• Ademetionine 3 · Hepatology / Gastroenterology
• Polyene Phosphatidyl choline
• Sector hub: All tracked pharma companies